BPLPHARMA · BPLPHARMA · Biotechnology & Drugs
Last close, 30 Oct
52-week high unavailable
52-week range: as of 30 Oct 2026.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Stock Condition as of 30 Oct 2026 close
Full signal detail →Chart
Fundamentals as of 15 Sep 2026 · the company's own latest record is 47 days old
Revenue (latest Q)
₹94 Cr
Revenue YoY
PAT YoY
-87.7%
Operating margin
Revenue, last 5 quarters
P/E (TTM)
P/B
4.1
P/S (TTM)
2.9
Sector P/E
36.3
Dividend yield
+0.1%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| BPLPHARMA (this stock) | Not meaningful (earnings negative over the last 12 months) | 4.1 | -4.8% | -4.8% | 0.45 | +0.1% |
| Sun Pharmaceutical Industries | 39.5 | 5.7 | +19.1% | +14.2% | 0.47 | +0.8% |
| Divi's Laboratories | 59.7 | 14.5 | +26.1% | +17.4% | 0 | +0.3% |
| Torrent Pharmaceuticals | 74.5 | 19.7 | +15.3% | +27.1% | 141.16 | +0.8% |
Promoter
stable
FII
stable
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
Governance disclosures
AI-generatedNo governance disclosures identified in BPLPHARMA's filed documents yet.